The nonmedical (i.e., recreational) misuse of synthetic cannabinoids (SCs) is a worldwide public health problem. When compared to cannabis, the misuse of SCs is associated with a higher incidence of serious adverse effects, suggesting the possible involvement of noncannabinoid sites of action. Here, we find that, unlike the phytocannabinoid Δ-tetrahydrocannabinol, the indole-moiety containing SCs, AM2201 and JWH-018, act as positive allosteric modulators (PAMs) at the 5-HT receptor (5-HTR). This suggests that some biological effects of SCs might involve allosteric interactions with 5-HTRs. To test this hypothesis, we examined effects of AM2201 on 5-HTR agonist-activated G protein-coupled inwardly rectifying potassium channel currents in neurons and on the hypothermic response to 5-HTR stimulation in mice lacking the cannabinoid receptor 1. We found that both 5-HTR effects were potentiated by AM2201, suggesting that PAM activity at 5-HTR may represent a novel noncannabinoid receptor mechanism underlying the complex profile of effects for certain SCs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275447 | PMC |
http://dx.doi.org/10.1021/acschemneuro.0c00034 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!